Advertisement
Screener

Immuneering Corporation (IMRX) Other

Immuneering Corporation Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-08-05: Form 10-Q; Item Shares outstanding CommonClassA as of 2026-07-31; As filed 64,697,402.
  • 2026-08-05: Form 10-Q; Item Shares outstanding CommonClassB as of 2026-07-31; As filed 0.
  • 2026-05-15: Form 10-Q; Item Shares outstanding CommonClassA as of 2026-05-11; As filed 64,697,402.
  • 2026-05-15: Form 10-Q; Item Shares outstanding CommonClassB as of 2026-05-11; As filed 0.
FiledFormItemAs filed
2026-08-0510-QShares outstanding CommonClassA as of 2026-07-3164,697,402
2026-08-0510-QShares outstanding CommonClassB as of 2026-07-310
2026-05-1510-QShares outstanding CommonClassA as of 2026-05-1164,697,402
2026-05-1510-QShares outstanding CommonClassB as of 2026-05-110
2026-03-0610-KShares outstanding CommonClassA as of 2026-03-0364,652,926
2026-03-0610-KShares outstanding CommonClassB as of 2026-03-030
2025-11-1210-QShares outstanding CommonClassA as of 2025-11-0564,569,967
2025-11-1210-QShares outstanding CommonClassB as of 2025-11-050
2025-08-1310-QShares outstanding CommonClassA as of 2025-08-1136,318,877
2025-08-1310-QShares outstanding CommonClassB as of 2025-08-110
2025-05-0510-QShares outstanding CommonClassA as of 2025-04-2835,985,702
2025-05-0510-QShares outstanding CommonClassB as of 2025-04-280
2025-03-2010-KShares outstanding CommonClassA as of 2025-03-1335,887,252
2025-03-2010-KShares outstanding CommonClassB as of 2025-03-130
2024-11-1310-QShares outstanding CommonClassA as of 2024-11-0631,050,448
2024-11-1310-QShares outstanding CommonClassB as of 2024-11-060
2024-08-0610-QShares outstanding CommonClassA as of 2024-07-3129,653,355
2024-08-0610-QShares outstanding CommonClassB as of 2024-07-310
2024-05-0710-QShares outstanding CommonClassA as of 2024-05-0129,653,355
2024-05-0710-QShares outstanding CommonClassB as of 2024-05-010
2024-03-0110-KShares outstanding CommonClassA as of 2024-02-2329,283,272
2024-03-0110-KShares outstanding CommonClassB as of 2024-02-230
2023-11-0910-QShares outstanding CommonClassA as of 2023-10-3129,269,121
2023-11-0910-QShares outstanding CommonClassB as of 2023-10-310
2023-08-0310-QShares outstanding CommonClassA as of 2023-07-2829,264,015
2023-08-0310-QShares outstanding CommonClassB as of 2023-07-280
2023-05-0410-QShares outstanding CommonClassA as of 2023-04-2729,248,656
2023-05-0410-QShares outstanding CommonClassB as of 2023-04-270
2023-03-0610-KShares outstanding CommonClassA as of 2023-02-2726,436,109
2023-03-0610-KShares outstanding CommonClassB as of 2023-02-270
2022-11-1010-QShares outstanding CommonClassA as of 2022-11-0326,404,732
2022-11-1010-QShares outstanding CommonClassB as of 2022-11-030
2022-08-1010-QShares outstanding CommonClassA as of 2022-08-0326,392,299
2022-08-1010-QShares outstanding CommonClassB as of 2022-08-030
2022-05-1010-QShares outstanding CommonClassA as of 2022-05-0326,385,299
2022-05-1010-QShares outstanding CommonClassB as of 2022-05-030
2022-03-1010-KShares outstanding CommonClassA as of 2022-03-0326,377,299
2022-03-1010-KShares outstanding CommonClassB as of 2022-03-030
2021-11-0910-QShares outstanding CommonClassA as of 2021-11-0325,940,564
2021-11-0910-QShares outstanding CommonClassB as of 2021-11-030
2021-09-0910-QStock registered under Section 12(b)Class A common Stock, par value $0.001 per share · IMRX · NASDAQ
2021-09-0910-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quantum Cyber N.V. (QUCY)$0.113B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80